glp-1 medications for obesity BodyByBariatrics Long-term Success of GLP-1s Hinges

Keep container tightly closed

Injectable protocols at peptide clinics typically use 1 to 5 mg per dose several times per week

Gerard L, Lecocq M, Bouzin C et al (2021) Increased angiotensin-converting enzyme 2 and loss of alveolar type II cells in COVID-19related acute respiratory distress syndrome

We see gradual, progressive loss of subcutaneous fat, degradation of collagen and elastin, and a flattening of the cheeks due to loss of malar projection, all of which contribute to an aged appearance. Weight loss induced by GLP-1 medications, however, accelerates these changes

References Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ